» Articles » PMID: 24992123

Evaluation of the Impact of a Pertussis Cocooning Program on Infant Pertussis Infection

Overview
Specialty Pediatrics
Date 2014 Jul 4
PMID 24992123
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tetanus, diphtheria and acellular pertussis immunization of infant contacts (cocooning) is recommended by the Centers for Disease Control and Prevention to prevent infant pertussis. We determined whether implementing a cocooning program at Ben Taub General Hospital, Houston, reduced severe pertussis in young infants.

Methods: Infants ≤6 months of age, diagnosed with pertussis (determined by International Classification of Diseases, Ninth Revision codes and microbiology records) at 4 hospitals, and born at times when only postpartum women (January 2008 through May 2009) and all infant contacts (June 2009 through August 2011) were offered tetanus, diphtheria and acellular pertussis vaccine at Ben Taub General Hospital were compared with infants born preintervention (May 2004 through December 2007).

Results: One hundred ninety-six (49%) infants with pertussis were born preintervention, 140 (35%) during maternal postpartum (PP) and 64 (16%) during cocooning (C) periods. Infants were similar in age at diagnosis (81.2 vs. 71.3 [PP] vs. 72.5 [C] days; P 0.07), sex (male 59% vs. 51% [PP] vs. 48% [C]; P 0.17), hospitalization (68% vs. 71% [PP] vs. 78% [C]; P 0.27) and outcome (2 deaths in the PP period; P 0.15), but more were admitted to intensive care units during cocooning (24% vs. 35% [PP] vs. 68% [C]; P < 0.001). Similar proportions of infants were born at Ben Taub General Hospital throughout the study (8% vs. 9% [PP] vs. 5% [C]; P 0.53).

Conclusions: Postpartum immunization and cocooning did not reduce pertussis illness in infants ≤6 months of age. Efforts should be directed toward increasing tetanus, diphtheria and acellular pertussis immunization during pregnancy, combined with cocooning, to reduce life-threatening young infant pertussis.

Citing Articles

Pertussis before, during and after Covid-19.

Locht C EMBO Mol Med. 2025; .

PMID: 39994481 DOI: 10.1038/s44321-025-00199-2.


Pertussis Epidemiology in Children: The Role of Maternal Immunization.

Principi N, Bianchini S, Esposito S Vaccines (Basel). 2024; 12(9).

PMID: 39340060 PMC: 11436108. DOI: 10.3390/vaccines12091030.


Pertussis vaccines, epidemiology and evolution.

Domenech de Celles M, Rohani P Nat Rev Microbiol. 2024; 22(11):722-735.

PMID: 38907021 DOI: 10.1038/s41579-024-01064-8.


Improving Tdap maternal immunization rate in Saudi Arabia.

Aldoosari A, Alosaimi B, Khalaf M Hum Vaccin Immunother. 2023; 19(2):2253585.

PMID: 37706510 PMC: 10503444. DOI: 10.1080/21645515.2023.2253585.


Safety and Clinical Benefits of Adacel and Adacel-Polio Vaccination in Pregnancy: A Structured Literature Review.

Clark L, Johnson D Infect Dis Ther. 2023; 12(8):1955-2003.

PMID: 37653123 PMC: 10505126. DOI: 10.1007/s40121-023-00847-5.